SKIP TO
CONTENT
Philips Recalled CPAP, Bi-Level PAP, and Mechanical...
featured news
April 9, 2014
Healthcare Fraud
Arkansas Supreme Court Takes Different View of Risperdal Fraud Case
Late last year, the federal Department of Justice settled a long-running dispute with drug maker Johnson & Johnson over allegations of the off-label marketing of the anti-psychotic drug Risperdal. As is often the case, Johnson & Johnson also faced several state False Claims Act and Deceptive Trade Practices Act allegations, […]
April 7, 2014
Healthcare Fraud
Ohio-Area Memorial Hospital to Pay $8.5 Million for False Claims Act Violations
Memorial Hospital, located in Fremont, Ohio, is a non-profit organization allegedly involved in improper billing practices for services provided to Medicare and Medicaid patients. It has also recently resolved allegations under the Stark Law involving unlawful financial relationships with other entities in the medical field. All in all, Memorial has […]
April 4, 2014
Healthcare Fraud
Medicare Fraud Case Takes Aim at Unnecessary Prescriptions of Dangerous Drug Clozapine
In a case involving Teva Pharmaceuticals USA, LLC, the Department of Justice recently settled hundreds of allegations of Medicare and Medicaid fraud relating to the improper recommendation of the generic drug clozapine – considered a drug of last resort for the treatment of schizophrenia. According to allegations, Teva, through its […]
April 3, 2014
Healthcare Fraud
Pittsburgh-Area West Penn Allegheny Health System Settles False Claims Act Case
In a recent settlement involving the False Claims Act’s anti-kickback provisions and the federal Stark Law, Pittsburgh’s West Penn Allegheny Health System has agreed to pay $1.5 million to settle claims it engaged in an unlawful exchange of benefits with Pittsburgh-area doctors and facilities. The case was handled by the […]
March 25, 2014
Healthcare Fraud
Off-Label Marketing and the First Amendment: Are Pharmaceutical Companies Protected?
The issue of off-label marketing raises a compelling question as to the relationship between the First Amendment’s protection of free speech and the various federal regulations prohibiting the practice of unlawful marketing of prescription drugs. As a review, off-label marketing occurs when a pharmaceutical company markets its product for use […]
schedule a free consultation
"*" indicates required fields
By clicking SUBMIT you agree to our Terms of Use and Privacy Policy and you are providing express consent to receive communications from Berger Montague via calls, emails, and/or text messages.
$50B+
in Settlements & Verdicts
53+
Years of High-Profile Cases
100+
Attorneys Protecting Your Rights
2X
Named “Trial Lawyer of the Year”
50
States in Which The Firm Has Successfully Litigated Cases
On the Cutting Edge of the Profession
Legal Intelligencer
53
Years
